HDI Publications in association with NDRS
A comparison of frailty measures in population-based data for patients with colorectal cancer
Birch R, Taylor J, Rahman T, Audisio R, Pilleron S, Quirke P, Howell S, Downing A, Morris E.
A comparison of ...
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study
Isaac Allen, Hend Hassan, Walburga Yvonne Joko-Fru, Catherine Huntley, Lucy Loong, Tameera Rahman, Bethany Torr, ...
The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource
Catherine Huntley, Lucy Loong, Corinne Mallinson, Rachel Bethell, Tameera Rahman, Neelam Alhaddad, Oliver Tulloch, ...
Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway
Fiona E McRonald, Joanna Pethick, Francesco Santaniello, Brian Shand, Adele Tyson, Oliver Tulloch, Shilpi Goel, ...
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA.
Cohort study to assess ...
Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England
Gannon MR, Dodwell D, Aggarwal A, Park MH, Miller K, Horgan K, et al. Br J Cancer 2023. ...
P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England
Amy Zalin-Miller, Sophie Jose, Sophia Le Mare, Betina Blak T ...
Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis
Wills, L., Nagarwalla, D., Pearson, C. et al.
Abstract:
The increasing burden of cancer has economic ...
Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers
Mahmoudpour SH, Knott CS, Amin A, Boutmy E, Verpillat P.
Integration of Immuno-oncology (IO) Treatments into ...
Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer
Goulden S, Heffernan K, Sen Nikitas F, et al.
Outcomes of dostarlimab versus chemotherapy in post-platinum ...
No results found.